ArticleMaterials today. Bio2026

An engineered ROS-responsive cascade nanoplatform delays Alzheimer's disease progression via Nrf2/GPX4-mediated microglial functional reprogramming.

Yang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.